Source:http://linkedlifedata.com/resource/pubmed/id/10533724
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-11-23
|
pubmed:abstractText |
The effects of transforming growth factor-alpha (TGF-alpha) on cell growth were studied in human glioma U251 cells transfected with antisense TGF-alpha vectors (pcDNAI.neo). Several antisense clones showed a marked decrease in growth rate in serum-free medium but not in medium containing 10% FBS, compared with those of parental cells and clones from sense or vector transfectants. Antisense clones also produced fewer and smaller colonies in anchorage-independent growth assays. Moreover, there was a reduction in TGF-alpha expression in these antisense clones at both the protein and mRNA levels, as determined by enzyme linked immuno-sorbent assay and reverse transcriptase polymerase chain reaction analysis. A U251 clone transfected by TGF-alpha antisense in a different vector (pMT/Ep) also showed a marked suppression in cell growth and TGF-alpha mRNA level. Finally, transfected clones with either vector system, showed decreased tumorigenicity in nude mice. In summary, a strong correlation between the inhibition of glioma cell growth and TGF-alpha expression was obtained from two different plasmid vectors, indicating that the expression of TGF-alpha could be specifically and effectively down-regulated by TGF-alpha antisense vector, which in turn led to growth inhibition. These studies suggests that TGF-alpha plays an essential role in controlling human glioma cell proliferation and may serve as a potential target for treatment of malignant glioma.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0167-594X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
127-35
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10533724-Animals,
pubmed-meshheading:10533724-Brain Neoplasms,
pubmed-meshheading:10533724-Cell Division,
pubmed-meshheading:10533724-Clone Cells,
pubmed-meshheading:10533724-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:10533724-Glioma,
pubmed-meshheading:10533724-Humans,
pubmed-meshheading:10533724-Mice,
pubmed-meshheading:10533724-Mice, Nude,
pubmed-meshheading:10533724-Oligodeoxyribonucleotides, Antisense,
pubmed-meshheading:10533724-Protein Biosynthesis,
pubmed-meshheading:10533724-RNA, Messenger,
pubmed-meshheading:10533724-Transcription, Genetic,
pubmed-meshheading:10533724-Transforming Growth Factor alpha,
pubmed-meshheading:10533724-Transplantation, Heterologous,
pubmed-meshheading:10533724-Tumor Cells, Cultured
|
pubmed:year |
1999
|
pubmed:articleTitle |
Transforming growth factor-alpha antisense vectors can inhibit glioma cell growth.
|
pubmed:affiliation |
Department of Neuro-oncology, The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|